Anavex Life Sciences Corp (AVXL)

[tootalljones]

this about sums it up on the 15 minute presentation:
20m
$AVXL
the dust will settle from last week soon. When experts in industry digest the data shred Friday, this data will gain the respect it deserves once all the data is fully peer-reviewed and published. Until then, if your struggling with what to do, I encourage you to revisit slide 15 (Episodic Memory). This is the hallmark for the diseases. For those in the 50mg treatment group you didn’t see your memory decline just slow or halt the decline...it reversed and improved for nearly every patient. No study I’ve seen has ever produced this breadth of response, nor magnitude of response here. That’s why this was the focus. Not cherry picking. It’s what should be in focus. Now look at slide 30 and imagine what could happen for these patients beyond 14 weeks...52 weeks, 148 weeks. Benefit may have a lot more room to run. This data will garner significant interest and investment, and those investors that can be patient for months will be rewarded.